Closure of the Novartis Direct Share Purchase Plan
Since June 20, 2016 Novartis no longer provides the Novartis Direct Share Purchase Plan managed and administered by SIX SAG Ltd on behalf of Novartis International AG. All the participants were informed by letter dated June 20, 2016 about the termination of the deposit agreement and the details regarding the available options and modalities. Openings of new deposits, transfers into existing deposits or executions of purchase orders are no longer possible through the Novartis Direct Share Purchase Plan.
In case of questions, please contact:
|Questions regarding the technical execution
of the transfer or the sale of your Novartis shares
|SIX SAG Ltd
+41 58 399 61 99
|Novartis Share Registry
+41 61 324 72 04
All information and documents concerning the Novartis Direct Share Purchase Plan (“Information and Documents”) are directed only at persons resident in Switzerland and do not constitute a solicitation or offer, or recommendation to buy or sell Novartis shares, to effect any transactions, to conclude any legal act of any kind whatsoever, or to subscribe to services made to persons residing in jurisdictions where such solicitation, offer or recommendation requires a local license.
The Information and Documents are not directed to any person in any jurisdiction where (by reason of that person's nationality, residence or otherwise) the publication or availability of the Novartis Webpage is prohibited. Persons in respect of whom such prohibitions apply must not access the Information and Documents.
The Direct Share Purchase Plan is regulated by Swiss Law.